Abstract:In September 2022, Uganda experienced an outbreak of Sudan virus disease (SVD), mainly in central Uganda. As a result of enhanced surveillance activities for Ebola disease, samples from several patients with suspected viral hemorrhagic fever (VHF) were sent to the VHF Program at Uganda Virus Research Institute (UVRI), Entebbe, Uganda, and identified with infections caused by other viral etiologies. Herein, we report the epidemiologic and laboratory findings of Crimean-Congo hemorrhagic fever (CCHF) cases that were detected during the SVD outbreak response. Whole blood samples from VHF suspected cases were tested for Sudan virus (SUDV) by real-time reverse transcription–polymerase chain reaction (RT-PCR); and if negative, were tested for CCHF virus (CCHFV) by RT-PCR. CCHFV genomic sequences generated by metagenomic next generation sequencing were analyzed to ascertain strain relationships. Between September 2022 and January 2023, a total of 2,626 samples were submitted for VHF testing at UVRI. Overall, 13 CCHF cases (including 7 deaths; case fatality rate of 53.8%), aged 4 to 60 years, were identified from 10 districts, including several districts affected by the SVD outbreak. Four cases were identified within the Ebola Treatment Unit (ETU) at Mubende Hospital. Most CCHF cases were males engaged in livestock farming or had exposure to wildlife (n = 8; 61.5%). Among confirmed cases, the most common clinical symptoms were hemorrhage (n = 12; 92.3%), fever (n = 11; 84.6%), anorexia (n = 10; 76.9%), fatigue (n = 9; 69.2%), abdominal pain (n = 9; 69.2%) and vomiting (n = 9; 69.2%). Sequencing analysis showed that the majority of identified CCHFV strains belonged to the Africa II clade previously identified in Uganda. Two samples, however, were identified with greater similarity to a CCHFV strain that was last reported in Uganda in 1958, suggesting possible reemergence. Identifying CCHFV from individuals initially suspected to be infected with SUDV emphasizes the need for comprehensive VHF testing during filovirus outbreak responses in VHF endemic countries. Without expanded testing, CCHFV-infected patients would have posed a risk to health care workers and others while receiving treatment after a negative filovirus diagnosis, thereby complicating response dynamics. Additionally, CCHFV-infected cases could acquire an Ebola infection while in the ETU, and upon release because of a negative Ebola virus result, have the potential to spread these infections in the community. Crimean-Congo hemorrhagic fever (CCHF) is a severe hemorrhagic disease whose symptoms mimic those of other viral hemorrhagic fevers (VHFs), significantly challenging its differential diagnosis. Herein, we report on CCHF cases that were detected during the nationwide response activities against an outbreak of Sudan virus (SUDV) in Uganda, from September 2022 to January 2023. Confirmed CCHF cases, mainly males presenting with a range of clinical signs and symptoms, were identified in districts with circulating SUDV, including 4 cases identified within an Ebola treatment center at Mubende hospital, thus complicating patient management and treatment. Our findings highlight the need for broad testing for VHFs and other high-consequence pathogens, even during known VHF outbreaks, in order to identify high risk pathogens with outbreak potential, especially in countries with a broad range of endemic zoonotic viral pathogens. This article also adds to the known molecular epidemiology of CCHF virus in Uganda.

Sudan virus disease super-spreading, Uganda, 2022

Sudan Virus Disease among Health Care Workers, Uganda, 2022

Ebola disease outbreak caused by the Sudan virus in Uganda, 2022: a descriptive epidemiological study

Time to care and factors influencing appropriate Sudan Virus Disease care among case patients in Uganda, September to November 2022

Performance and impact of contact tracing in the Sudan Virus Outbreak in Uganda, September 2022–January 2023

2022 Sudan Ebolavirus Outbreak in Uganda: Modelling Case Burden and Outbreak Duration.

Crimean-Congo hemorrhagic fever cases diagnosed during an outbreak of Sudan virus disease in Uganda, 2022–23

Individual and household risk factors for Ebola disease among household contacts in Mubende and Kassanda districts, Uganda, 2022

Stigma among Ebola Disease Survivors in Mubende and Kassanda districts, Central Uganda, 2022

Epidemiological description of Marburg virus disease outbreak in Kagera region, Northwestern Tanzania

Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021

Genomic characterization uncovers transmission dynamics of Marburg Virus in Rwanda following a single zoonotic spillover event

1762. Clinical application of handheld ultrasound devices during the 2022 Sudan Virus disease Ebola outbreak in Uganda

On alert for Ebola: public health risk assessment of travellers from Uganda to the USA during the 2022 outbreak

Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination

Monkeypox pandemic in Sudan, surveillance epidemiologic report, 2022

Challenges and epidemiological implications of the first outbreak of dengue and chikungunya in Sudan

Infection prevention and control of highly infectious pathogens in resource-limited countries: an experience from Marburg viral disease outbreak in Kagera Region - Tanzania

Marburg virus disease outbreak in Tanzania: current efforts and recommendations - a short communication

Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda

Viruses associated with measles-like illnesses in Uganda